The Latest: Vaccine-maker BioNTech sees profits soar in Q2
BERLIN - German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, saw its profits surge in the second quarter of 2021. |!| Woons…
BERLIN - German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, saw its profits surge in the second quarter of 2021. |!| Woons…